Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Influence Of Protamine Shell On Nanoemulsions As A Carrier For Cyclosporine-A Skin Delivery
M. J. Alvarez-Figueroa, José María Abarca-Riquelme, J. V. González-Aramundiz
Published 2019 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Abstract Novel protamine-based nanosystems have been studied for cyclosporine-A (CsA) skin delivery. Core-shell structure systems have been developed to this end. These vehicles have particles sizes of 200–300 nm, a low polydispersity index and a zeta potential which varies between −16 mV and +35 mV. The resulting four nanosystems efficiently encapsulated CsA in their oily nucleus (60–80%) and released this drug in a controlled manner. These formulations have shown a high stability in aqueous suspension in storage conditions at 4 °C (for at least 21 months) and in acetate buffer at a physiological temperature of 37 °C (for at least 24 h). Ex vivo transdermal diffusion experiments using Franz diffusion cells and 2- to 3-day-old pig skin as a biological barrier were performed. All nanoformulations designed produced an increase in CsA transdermal delivery and two of these nanosystems presented a marked promoting effect; the more relevant parameters were smaller particle size (200 ± 7 nm) and negative superficial charge. Finally, the ability of these nanosystems to enhance retention of CsA in the skin was also studied. The protamine disposition in the shell influenced CsA skin retention. Therefore, the incorporation of CsA into the nanosystems studied here makes them suitable vehicles for CsA transdermal administration. Graphical Abstract
This paper references
Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune System
Mercedes Peleteiro (2018)
Lecithin vesicular carriers for transdermal delivery of cyclosporin A.
J. Guo (2000)
Polyarginine nanocapsules: a new platform for intracellular drug delivery
M. V. Lozano (2013)
Liposome surface charge influence on skin penetration behaviour.
A. Gillet (2011)
Stability of nanosuspensions in drug delivery.
Y. Wang (2013)
Size-dependent penetration of nanoemulsions
Y Li (2017)
Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
Morteza Amjadi (2017)
Topical delivery of Cyclosporine A into the skin using SPACE-peptide.
Ming Chen (2015)
Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization
R. Su (2017)
Protamine as an efficient membrane-translocating peptide.
F. Reynolds (2005)
Rational design of protamine nanocapsules as antigen delivery carriers
J. V. González-Aramundiz (2017)
Percutaneous penetration studies for risk assessment.
Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Jie Shen (2010)
Nanotechnology and the transdermal route: A state of the art review and critical appraisal.
G. Cevc (2010)
Unusual solubility behaviour of cyclosporin A in aqueous media
G. Ismailos (1991)
In vitro skin models as a tool in optimization of drug formulation.
G. E. Flaten (2015)
Chapter 6.1:Physiological and Mechanistic Issues of the Skin Barrier
M. J. Alvarez-Figueroa (2012)
Surface-charge-dependent nanoparticles accumulation in inflamed skin.
Mona M A Abdel-Mottaleb (2012)
Porcine ear skin: an in vitro model for human skin
U. Jacobi (2007)
In‐vitro permeation of drugs into porcine hair follicles: is it quantitatively equivalent to permeation into human hair follicles?
Yakov Frum (2008)
Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery
K. Malinovskaja-Gomez (2017)
Development and characterization of nanocapsules comprising dodecyltrimethylammonium chloride and κ-carrageenan.
A. Rosas-Durazo (2011)
The use of cyclosporine in dermatology: part I.
Karrie T Amor (2010)
Nanoparticles skin absorption: New aspects for a safety profile evaluation.
F. Larese Filon (2015)
Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
S. Mahmood (2018)
Influence of Protamine Functionalization on the Colloidal Stability of 1D and 2D Titanium Oxide Nanostructures.
Paul Rouster (2017)
Management of injected hyaluronic acid induced Tyndall effects
R. Hirsch (2006)
Classes of Cell-Penetrating Peptides.
M. Pooga (2015)
Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer.
L. B. Lopes (2005)
Methods for quantitative determination of drug localized in the skin.
E. Touitou (1998)
Lower-Sized Chitosan Nanocapsules for Transcutaneous Antigen Delivery
Juan I. Bussio (2018)
Percutaneous absorption and dermal delivery of cyclosporin A.
H. Choi (1995)
Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis
M. Naeem (2018)
Aggregation kinetics and colloidal stability of functionalized nanoparticles.
F. Gambinossi (2015)
Effect of Size and Surface Charge of Gold Nanoparticles on their Skin Permeability: A Molecular Dynamics Study
R. Gupta (2017)
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
Lungile Nomcebo Thwala (2016)
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
A. Kohli (2004)
Development and characterization of nanocapsules comprising dodecyltrimethylammonium chloride and j-carrageenan
A Rosas-Durazo (2011)
Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
M. Pradhan (2015)
Essential oils in niosomes for enhanced transdermal delivery of felodipine
Rania K Eid (2019)
Delivery of oat‐derived phytoceramides into the stratum corneum of the skin using nanocarriers: Formulation, characterization and in vitro and ex‐vivo penetration studies
Efrem N. Tessema (2018)
Lipid-protamine-DNA-mediated antigen delivery.
D. P. Vangasseri (2005)
Iontophoresis of lecithin vesicles of cyclosporin A.
R. Boinpally (2004)
Skin permeabilization for transdermal drug delivery: recent advances and future prospects
Carl M Schoellhammer (2014)
Preparation and characterization of solid lipid
Z Urb an-Morl an (2010)
Potential applications and human biosafety of nanomaterials used in nanomedicine
H. Su (2018)
drug delivery and drug targeting
CM Schoellhammer (2014)
Ultra high performance liquid chromatography-tandem mass spectrometry method for cyclosporine a quantification in biological samples and lipid nanosystems.
M. Guada (2013)
Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics.
M. M. Kanchi (2017)
Polymeric nanocapsules: a potential new therapy for corneal wound healing
S. Reimondez-Troitiño (2016)
Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles.
S. Jóhannsdóttir (2017)
Cell-penetrating peptides. Methods and protocols
G. Wiederschain (2011)
Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
Z. Urbán-Morlán (2010)
Diverse Applications of Nanomedicine
B. Pelaz (2017)
Protamine Nanocapsules for the Development of Thermostable Adjuvanted Nanovaccines.
J. V. González-Aramundiz (2018)
Passive and Iontophoretic Transdermal Penetration of Chlorpromazine
M. J. Alvarez-Figueroa (2008)
New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis.
J. Roujeau (2017)
Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting.
B. Scheicher (2015)
Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
G. Lollo (2015)
Passive and iontophoretic transdermal penetration of chlorpromazine.
M. J. Alvarez-figueroa (2008)
Ostwald Ripening and Related Phenomena
A. Kabalnov (2001)
Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
S. Kim (2009)
THE PROTAMINE SALTS OF PHOSPHATIDES, WITH REMARKS ON THE PROBLEM OF LIPOPROTEINS
E. Chargaff (1938)
In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes.
S. Gao (1998)
Investigation into the potential of low-frequency ultrasound facilitated topical delivery of Cyclosporin A.
Hongzhuo Liu (2006)
Development and Characterization
M. Hebsur (1998)
Skin models for the testing of transdermal drugs
E. Abd (2016)
Expert Opin Drug Deliv
J Shen (2010)
Towards tailored vaccine delivery: needs, challenges and perspectives.
Jean-Pierre Amorij (2012)
Protamines: structural complexity, evolution and chromatin patterning.
H. Kasinsky (2011)
Protamine-based nanoparticles as new antigen delivery systems.
J. V. González-Aramundiz (2015)
The use of cyclosporine in dermatology: part II.
C. Ryan (2010)
In Vitro, ex vivo, and in vivo evaluation of a dual pH/redox responsive nanoliposomal sludge for transdermal drug delivery
S Mavuso (2018)
Polypeptides and polyaminoacids in drug delivery
J. V. González-Aramundiz (2012)
Cyclosporin A--a review on fermentative production, downstream processing and pharmacological applications.
S. Survase (2011)
Transdermal patches: history, development and pharmacology
M. N. Pastore (2015)
Microfluidic-Enabled Liposomes Elucidate Size-Dependent Transdermal Transport
R. R. Hood (2014)
Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach.
S. Onoue (2010)
This paper is referenced by
Cyclosporine A Loaded Nanoemulsions using Bio-oil Fractions of Sesame Oil
S. Bhargava (2020)
Hyaluronic Acid Nanocapsules as a Platform for Needle-Free Vaccination
Juan I. Bussio (2019)
Ultraflexible lipid vesicles allow topical absorption of cyclosporin A
J. J. Carreras (2019)
Design of Chitosan Nanocapsules with Compritol 888 ATO® for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy.
M. J. Alvarez-Figueroa (2020)
Dissolving Microneedle Arrays with Optimized Needle Geometry for Transcutaneous Immunization.
Y. Li (2020)
Freeze-Dried Softisan® 649-Based Lipid Nanoparticles for Enhanced Skin Delivery of Cyclosporine A
M. I. Silva (2020)